top of page
Search


Evaluating the Safety, Tolerability, and Biodistribution of RCT2100 with Single-Ascending Doses in Healthy Participants and Multiple-Ascending Doses and Proof-of-Concept in Participants with CF
Evaluating the Safety, Tolerability, and Biodistribution of RCT2100 with Single-Ascending Doses in Healthy Participants and Multiple-Ascending Doses and Proof-of-Concept in Participants with CF
Glenn Hearson
Jun 26


New NIHR Nottingham BRC Funded Research; Understanding novel Point of Care testing of Alkyl Quinolones for Pseudomonas Aeruginosa (UnPAQ) – a feasibility study
New NIHR Nottingham BRC Funded Research; Understanding novel Point of Care testing of Alkyl Quinolones for Pseudomonas Aeruginosa (UnPAQ)
Glenn Hearson
Apr 4


Investigating The Effects of Yoga Practice on Adults with Cystic Fibrosis
Investigating The Effects of Yoga Practice on Adults with Cystic Fibrosis
-
Jul 24, 2024


Artificial intelligence to Control acute pulmonary Exacerbations in Cystic Fibrosis
Artificial intelligence to Control acute pulmonary Exacerbations in Cystic Fibrosis
-
Jul 24, 2024


Respiratory Research Day: Universities of Nottingham, Leicester and @NottmBRCLung, @LeicesterBRC
We want to say a huge thank you to everyone who attended the University of Nottingham & University of Leicester Joint Respiratory...
-
May 17, 2023


New Body Plethysmography Box has arrived for ultra high quality, accurate lung function tests
Our brand new Vyntus Body Plethysmography Box or "Body Box" as we refer to it has finally arrived. Our lung function specialist, Paula...
-
Nov 11, 2022


Impact of ELX/TEZ/IVA on Patients With Cystic Fibrosis (TRAJECTORY)
We have recently commenced a new study in conjunction with with Vertex Pharmaceuticals Incorporated and Cardiff and Vale University...
-
Aug 15, 2022


Experts from the University of Nottingham to develop new treatments for cystic fibrosis infections
Experts from the University of Nottingham have joined a Strategic Research Centre as part of a new international collaboration led by...
-
Oct 29, 2021
bottom of page